GFAP and chronic kidney disease: Prior studies, including our own, have reported that CKD is associated with higher levels of plasma pTau-181, NfL, and GFAP, and lower Aβ42/40, poorer cognitive function, accelerated cognitive decline over 7 years, and higher MCI prevalence38,40.